These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30794654)

  • 1. ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism.
    Morozumi N; Yotsumoto T; Yamaki A; Yoshikiyo K; Yoshida S; Nakamura R; Jindo T; Furuya M; Maeda H; Minamitake Y; Kangawa K
    PLoS One; 2019; 14(2):e0212680. PubMed ID: 30794654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of novel natriuretic peptide derivatives with improved pharmacokinetic and pharmacodynamic properties.
    Morozumi N; Sato S; Yoshida S; Harada Y; Furuya M; Minamitake Y; Kangawa K
    Peptides; 2017 Nov; 97():16-21. PubMed ID: 28899838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety assessment of a novel C-type natriuretic peptide derivative and the mechanism of bone- and cartilage-specific toxicity.
    Yotsumoto T; Morozumi N; Nakamura R; Jindo T; Furuya M; Abe Y; Nishimura T; Maeda H; Ogasawara H; Minamitake Y; Kangawa K
    PLoS One; 2019; 14(9):e0218229. PubMed ID: 31509532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neprilysin Inhibition Promotes Skeletal Growth via the CNP/NPR-B Pathway.
    Hakata T; Ueda Y; Yamashita T; Yamauchi I; Kosugi D; Sugawa T; Fujita H; Okamoto K; Fujii T; Taura D; Yasoda A; Akiyama H; Inagaki N
    Endocrinology; 2024 May; 165(7):. PubMed ID: 38752331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating osteocrin stimulates bone growth by limiting C-type natriuretic peptide clearance.
    Kanai Y; Yasoda A; Mori KP; Watanabe-Takano H; Nagai-Okatani C; Yamashita Y; Hirota K; Ueda Y; Yamauchi I; Kondo E; Yamanaka S; Sakane Y; Nakao K; Fujii T; Yokoi H; Minamino N; Mukoyama M; Mochizuki N; Inagaki N
    J Clin Invest; 2017 Nov; 127(11):4136-4147. PubMed ID: 28990933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exogenous C-type natriuretic peptide restores normal growth and prevents early growth plate closure in its deficient rats.
    Hirota K; Furuya M; Morozumi N; Yoshikiyo K; Yotsumoto T; Jindo T; Nakamura R; Murakami K; Ueda Y; Hanada T; Sade H; Yoshida S; Enomoto K; Kanai Y; Yamauchi I; Yamashita T; Ueda-Sakane Y; Fujii T; Yasoda A; Inagaki N
    PLoS One; 2018; 13(9):e0204172. PubMed ID: 30235256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3-Related Skeletal Dysplasias.
    Breinholt VM; Rasmussen CE; Mygind PH; Kjelgaard-Hansen M; Faltinger F; Bernhard A; Zettler J; Hersel U
    J Pharmacol Exp Ther; 2019 Sep; 370(3):459-471. PubMed ID: 31235532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of C-type natriuretic peptide signalling in maintaining cartilage and bone function.
    Peake NJ; Hobbs AJ; Pingguan-Murphy B; Salter DM; Berenbaum F; Chowdhury TT
    Osteoarthritis Cartilage; 2014 Nov; 22(11):1800-7. PubMed ID: 25086404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic responses of plasma and tissue C-type natriuretic peptide to GH: correlation with linear growth in GH-deficient rats.
    Prickett TC; Bothwell JC; Yandle TG; Richards AM; Espiner EA
    J Endocrinol; 2012 Feb; 212(2):217-25. PubMed ID: 22087017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic GMP-dependent protein kinase II plays a critical role in C-type natriuretic peptide-mediated endochondral ossification.
    Miyazawa T; Ogawa Y; Chusho H; Yasoda A; Tamura N; Komatsu Y; Pfeifer A; Hofmann F; Nakao K
    Endocrinology; 2002 Sep; 143(9):3604-10. PubMed ID: 12193576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-type natriuretic peptide in growth: a new paradigm.
    Olney RC
    Growth Horm IGF Res; 2006 Jul; 16 Suppl A():S6-14. PubMed ID: 16716628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rats deficient C-type natriuretic peptide suffer from impaired skeletal growth without early death.
    Fujii T; Hirota K; Yasoda A; Takizawa A; Morozumi N; Nakamura R; Yotsumoto T; Kondo E; Yamashita Y; Sakane Y; Kanai Y; Ueda Y; Yamauchi I; Yamanaka S; Nakao K; Kuwahara K; Jindo T; Furuya M; Mashimo T; Inagaki N; Serikawa T; Nakao K
    PLoS One; 2018; 13(3):e0194812. PubMed ID: 29566041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-type natriuretic peptide restores impaired skeletal growth in a murine model of glucocorticoid-induced growth retardation.
    Ueda Y; Yasoda A; Yamashita Y; Kanai Y; Hirota K; Yamauchi I; Kondo E; Sakane Y; Yamanaka S; Nakao K; Fujii T; Inagaki N
    Bone; 2016 Nov; 92():157-167. PubMed ID: 27594049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Local CNP/GC-B system in growth plate is responsible for physiological endochondral bone growth.
    Nakao K; Osawa K; Yasoda A; Yamanaka S; Fujii T; Kondo E; Koyama N; Kanamoto N; Miura M; Kuwahara K; Akiyama H; Bessho K; Nakao K
    Sci Rep; 2015 May; 5():10554. PubMed ID: 26014585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNP signal pathway up-regulated in rectum of depressed rats and the interventional effect of Xiaoyaosan.
    Li P; Tang XD; Cai ZX; Qiu JJ; Lin XL; Zhu T; Owusu L; Guo HS
    World J Gastroenterol; 2015 Feb; 21(5):1518-30. PubMed ID: 25663771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 8-Nitro-cGMP promotes bone growth through expansion of growth plate cartilage.
    Hoshino M; Kaneko K; Miyamoto Y; Yoshimura K; Suzuki D; Akaike T; Sawa T; Ida T; Fujii S; Ihara H; Tanaka J; Tsukuura R; Chikazu D; Mishima K; Baba K; Kamijo R
    Free Radic Biol Med; 2017 Sep; 110():63-71. PubMed ID: 28559051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells.
    Ozasa A; Komatsu Y; Yasoda A; Miura M; Sakuma Y; Nakatsuru Y; Arai H; Itoh N; Nakao K
    Bone; 2005 Jun; 36(6):1056-64. PubMed ID: 15869918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
    Sellitti DF; Puggina E; Lagranha C; Doi SQ
    J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dwarfism and early death in mice lacking C-type natriuretic peptide.
    Chusho H; Tamura N; Ogawa Y; Yasoda A; Suda M; Miyazawa T; Nakamura K; Nakao K; Kurihara T; Komatsu Y; Itoh H; Tanaka K; Saito Y; Katsuki M; Nakao K
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4016-21. PubMed ID: 11259675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-type natriuretic peptide regulates endochondral bone growth through p38 MAP kinase-dependent and -independent pathways.
    Agoston H; Khan S; James CG; Gillespie JR; Serra R; Stanton LA; Beier F
    BMC Dev Biol; 2007 Mar; 7():18. PubMed ID: 17374144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.